NCT07259629

Brief Summary

Fasting is a requirement to safely anesthetise patients referred for elective procedure, using the traditional 6/4/2 rule (6h for solid food or formula milk, 4h for breast milk and 2h for clear fluids), applied to all patients regardless of their age or weight. Reducing the aspiration risk however puts young children at higher risk of hypoglycemia due to the immaturity of their endocrine system and absence of metabolic reserves. The Association of Paediatric Anaesthetists of Great Britain and Ireland recommends that during day case surgery the majority of children may be given fluids without dextrose, provided blood glucose is monitored. Recent statements recommend continuing fluids until 1h before the procedure or even to give fluids when anesthetists sent for the patients. Hypoglycemia is rare in children above 2 years of age. Although the definition of hypoglycemia can differ, a threshold of 3.6mmol/l is often used given the potential neurological harm existing below this value. There is no consensus on the definition of hypoglycemia in children being fasted prior to general anesthesia, nor when nor how to treat it. Measurements are done for complex surgeries or patients deemed at risk according to the anesthetists. An audit was run in 2017 at the " Evelina London Children's Hospital ", Guy's and St Thomas' National Health Service Foundation Trust, identifying 8% of children below 2 years of age as hypoglycemic. Recent review of our Incident Reporting Systems identified 3 cases, in otherwise fit and healthy children, referred for colonoscopy with initial hypoglycemia followed by rebound hypoglycemia after management. There is an urgent need to establish a clear definition of hypoglycemia and investigate risk factors in paediatric patients referred for elective procedures under general anesthesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,902

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2025

Shorter than P25 for all trials

Geographic Reach
1 country

24 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 16, 2024

Completed
10 months until next milestone

Study Start

First participant enrolled

May 12, 2025

Completed
7 months until next milestone

First Posted

Study publicly available on registry

December 2, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 18, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 18, 2026

Completed
Last Updated

July 22, 2026

Status Verified

July 1, 2026

Enrollment Period

1 year

First QC Date

July 16, 2024

Last Update Submit

July 20, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Hypoglycaemia

    Blood glucose values triggering a response from the anaesthetists with initiation of a hypoglycaemia treatment following a blood glucose measurement during anaesthetic induction. Decision to diagnose hypoglycaemia and treat it by the anaesthetist

    Immediately/within five minutes after anesthesia induction

Secondary Outcomes (7)

  • 4mmol/l as a suitable threshold of hypoglycemia

    Immediately/within five minutes after anesthesia induction

  • Distribution of glycemic measurements in fasting children

    Immediately/within five minutes after anesthesia induction

  • Age as a risk factor of hypoglycaemia

    Immediately/within five minutes after anesthesia induction

  • Weight as a risk factor of hypoglycaemia

    Immediately/within five minutes after anesthesia induction

  • Distribution of blood ketone measurements in children fasting

    Immediately/within five minutes after anesthesia induction

  • +2 more secondary outcomes

Eligibility Criteria

Age1 Month - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Pediatric patients fasting for a procedure under general anesthesia

You may qualify if:

  • All American Society of Anesthesiology score (ASA) 1 - 3 children aged 1 month to 18 years presenting for an elective procedure involving general anaesthesia during the defined study period
  • All elective cases, day cases will be included (patient's admitted the night before for bowel preparation prior to elective colonoscopy should also be included)
  • Planned expedited cases in ASA 1 / 2 children should be included, for example nail bed repairs, lacerations, foreign body (in ear / eye / nose), simple fractures for manipulation under anesthesia / k-wires
  • MRI, radiology and dental cases will be included provided the patient receives a general anaesthetic

You may not qualify if:

  • Children aged less than 1 month
  • Procedures performed under oral sedation or local anaesthesia only
  • ASA status 4 and 5
  • Children with any endocrine or metabolic condition or who have a fasting plan prior to general anaesthesia for glucose control:
  • Type 1 or 2 diabetes mellitus, medium chain acetyl Co-enzyme A, maple syrup urine disease, glycogen storage disease, galactosaemia, urea cycle defects, familial hypercholesterolaemia, congenital disorders of glycosylation, lysosomal storage disorders, organic acidaemias, mitochondrial disorders, adrenal gland disorders, adrenoleukodystrophy, growth disorders, lipid disorders, multiple endocrine neoplasia type 1 and 2, pituitary disorders.
  • Emergency and oncology procedures as these children will have different risk factors for hypoglycaemia
  • Anaesthetic involvement in critically ill children e.g. airway management in emergency department, pediatric intensive care unit
  • Children on glucose containing intravenous solutions or total parenteral nutrition pre-operatively
  • Children on systemic steroid treatment (oral / intravenous). Children on inhalers / topical steroids should be included

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (24)

Royal Devon University Healthcare NHS Foundation Trust

Exeter, Devon, EX2 5DW, United Kingdom

Location

Royal Aberdeen Infirmary

Aberdeen, United Kingdom

Location

Royal Belfast Hospital for Sick Children

Belfast, United Kingdom

Location

Ulster Hospital

Belfast, United Kingdom

Location

Birmingham Women and Children's Hospital

Birmingham, United Kingdom

Location

Addenbrooke's Hospital

Cambridge, United Kingdom

Location

Children's Hospital of Wales

Cardiff, United Kingdom

Location

Ninewells Tayside Hospital

Dundee, United Kingdom

Location

Royal Hospital for Sick Children

Edinburgh, United Kingdom

Location

Royal Hospital for Children

Glasgow, United Kingdom

Location

Buckinghamshire Healthcare NHS Foundation Trust

High Wycombe, United Kingdom

Location

Moorfields Eye Hospital

London, EC1V 2PD, United Kingdom

Location

Evelina London Children's Hospital

London, SE17EH, United Kingdom

Location

Chelsea and Westminster Hospital

London, United Kingdom

Location

King's College Hospital

London, United Kingdom

Location

Royal London Hospital

London, United Kingdom

Location

St George's Hospital

London, United Kingdom

Location

St Mary's Hospital

London, United Kingdom

Location

James Cook University Hospital

Middlesbrough, United Kingdom

Location

Great Northern Children's Hospital

Newcastle, United Kingdom

Location

Nottingham Children's Hospital

Nottingham, United Kingdom

Location

University hospital of Plymouth

Plymouth, United Kingdom

Location

Salisbury NHS Foundation Trust

Salisbury, United Kingdom

Location

Sheffield Children's Hospital

Sheffield, United Kingdom

Location

MeSH Terms

Conditions

Hypoglycemia

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 16, 2024

First Posted

December 2, 2025

Study Start

May 12, 2025

Primary Completion

May 18, 2026

Study Completion

May 18, 2026

Last Updated

July 22, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations